Study #2015-0936
Phase II Trial of Salvage Radiation Therapy to Induce Systemic Disease Regression after Progression on Systemic Immunotherapy
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This phase II trial studies the side effects and best dose of radiation therapy and to see how well it works in treating patients with cancer that has spread to other places in the body (metastatic) or has increased in size after being treated with immunotherapy. Giving radiation therapy may help to control the cancer after the disease has gotten worse after receiving immunotherapy in patients with cancer that has spread to the other places in the body.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Hematopoietic and Lymphoid Cell Neoplasm;Metastatic Malignant Solid Neoplasm
Study phase:
Phase II
Physician name:
James Welsh
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.